(Q37867695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Drug-induced liver injury: a summary of recent advances (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

James H Lewis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

21 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

875-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

Drug-induced acute liver failure: results of a U.S. multicenter, prospective study

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Important elements for the diagnosis of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Predicting and preventing acute drug-induced liver injury: what's new in 2010?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Risk factors for idiosyncratic drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Gastrointestinal and liver side effects of drugs in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Use of statins in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Review article: The use of potentially hepatotoxic drugs in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

The myth of statin-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Isoniazid-induced apoptosis in HepG2 cells: generation of oxidative stress and Bcl-2 down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Pharmacogenetics of antiretrovirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Drug-induced liver injury in humans: the case of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Mechanisms of immune-mediated liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Role of reactive metabolites in drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxic effects of therapies for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Clinical syndromes and consequences of antiretroviral-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Clarifying metformin's role and risks in liver dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Low-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Complementary and alternative medicine use in chronic liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity due to hydroxycut: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Liver disease and cirrhosis because of Khat chewing in UK Somali men: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity of khat chewing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity of agents used in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Successful treatment with erlotinib after gefitinib-related severe hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Adalimumab-induced autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Severe drug-induced liver injury associated with prolonged use of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Azithromycin-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Hepatotoxicity of alpha-methyldopa in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Procarbazine-induced hepatotoxicity: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Calcineurin inhibitor-related cholestasis complicating lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Toxic hepatitis induced by Gymnema sylvestre, a natural remedy for type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

Aloe-induced toxic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.577415

10.1517/17425255.2011.577415

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21510822%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference